Takafumi Suda Selected Research

Takafumi Suda Research Topics

Disease

44	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 07/2003
40	Neoplasms (Cancer) 10/2022 - 12/2004
38	Idiopathic Pulmonary Fibrosis 01/2022 - 07/2005
35	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022 - 09/2003
25	Asthma (Bronchial Asthma) 05/2022 - 09/2002
19	Lung Neoplasms (Lung Cancer) 01/2022 - 09/2003
17	Inflammation (Inflammations) 01/2022 - 09/2002
17	Infections 02/2021 - 01/2005
16	Chronic Obstructive Pulmonary Disease (COPD) 05/2022 - 12/2008
16	Disease Progression 01/2022 - 03/2010
16	Pneumonia (Pneumonitis) 03/2021 - 04/2004
12	Dermatomyositis (Dermatopolymyositis) 01/2022 - 05/2009
12	Idiopathic Interstitial Pneumonias 01/2022 - 01/2006
12	Respiratory Insufficiency (Respiratory Failure) 01/2020 - 09/2002
11	Sarcoidosis (Schaumann Disease) 08/2020 - 01/2005
10	Adenocarcinoma of Lung 01/2022 - 01/2017
10	Vascular Diseases (Vascular Disease) 03/2021 - 07/2006
10	Lung Diseases (Lung Disease) 01/2021 - 04/2008
9	Nausea 03/2022 - 06/2014
9	Cough 04/2016 - 12/2006
8	Fibrosis (Cirrhosis) 01/2021 - 07/2005
8	Rheumatoid Arthritis 08/2020 - 09/2008
8	Dyspnea (Shortness of Breath) 08/2019 - 12/2006
7	Vomiting 03/2022 - 06/2014
7	Tuberculosis (Tuberculoses) 03/2012 - 04/2006
6	Hemorrhage 01/2020 - 07/2005
6	Hypoxia (Hypoxemia) 01/2019 - 01/2008
6	Neoplasm Metastasis (Metastasis) 12/2018 - 11/2013
6	Fever (Fevers) 05/2018 - 12/2006
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 08/2015
5	Granuloma 04/2016 - 06/2002
4	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2022 - 06/2015
4	Connective Tissue Diseases (Connective Tissue Disease) 01/2022 - 10/2010
4	Cryptogenic Organizing Pneumonia 01/2022 - 10/2004
4	Myositis (Idiopathic Inflammatory Myopathies) 01/2022 - 01/2014
4	Organizing Pneumonia 11/2020 - 01/2007
4	Breast Neoplasms (Breast Cancer) 04/2020 - 10/2004
4	Bronchiectasis 01/2018 - 01/2013
4	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 04/2016 - 12/2006
4	Pleural Effusion (Pleural Effusions) 01/2016 - 06/2002
3	Carcinogenesis 10/2022 - 09/2003
3	Death (Near-Death Experience) 04/2022 - 11/2020
3	Adenocarcinoma 01/2022 - 01/2017
3	Amyopathic dermatomyositis 01/2022 - 05/2009
3	Eosinophilia 01/2022 - 09/2013

Drug/Important Bio-Agent (IBA)

30	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2021 - 09/2005
14	Proteins (Proteins, Gene)FDA Link 07/2022 - 02/2008
14	Pharmaceutical PreparationsIBA 01/2022 - 11/2004
14	Biomarkers (Surrogate Marker)IBA 11/2021 - 11/2011
13	Carboplatin (JM8)FDA LinkGeneric 03/2022 - 09/2012
13	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 09/2006
12	CollagenIBA 03/2021 - 07/2006
11	AutoantibodiesIBA 01/2022 - 01/2006
11	SteroidsIBA 04/2019 - 09/2002
10	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 07/2005
9	AntibodiesIBA 01/2022 - 01/2008
8	AntiemeticsIBA 03/2022 - 06/2014
8	ErbB Receptors (EGF Receptor)IBA 01/2021 - 08/2011
8	Messenger RNA (mRNA)IBA 01/2020 - 09/2002
7	Dexamethasone (Maxidex)FDA LinkGeneric 03/2022 - 06/2014
7	Immune Checkpoint InhibitorsIBA 10/2021 - 05/2016
7	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 08/2011
7	EnzymesIBA 01/2021 - 09/2008
7	CytokinesIBA 03/2019 - 09/2002
7	VaccinesIBA 11/2015 - 04/2008
6	NivolumabIBA 02/2022 - 01/2019
6	LigandsIBA 02/2022 - 07/2005
6	pirfenidoneIBA 07/2021 - 01/2014
6	Methotrexate (Mexate)FDA LinkGeneric 07/2021 - 05/2012
6	Anti-Bacterial Agents (Antibiotics)IBA 02/2021 - 04/2008
6	ImmunosorbentsIBA 01/2021 - 09/2008
6	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 05/2008
6	AntigensIBA 01/2020 - 06/2002
6	Budesonide (Pulmicort)FDA LinkGeneric 01/2019 - 09/2005
5	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2022 - 01/2015
5	LipidsIBA 01/2022 - 01/2005
5	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2016
5	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021 - 07/2003
5	Peroxidase (Myeloperoxidase)IBA 01/2021 - 05/2008
5	Formoterol Fumarate (Oxis)FDA Link 01/2019 - 06/2012
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 07/2005
5	Therapeutic UsesIBA 01/2015 - 05/2008
4	Oxygen (Dioxygen)IBA 04/2022 - 03/2017
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 07/2015
4	Immunoglobulin G (IgG)IBA 01/2022 - 07/2005
4	Mannose ReceptorIBA 02/2020 - 01/2018
4	Rifampin (Rifampicin)FDA LinkGeneric 01/2020 - 04/2006
4	Clarithromycin (Biaxin)FDA LinkGeneric 01/2020 - 09/2005
4	Immunoglobulin E (IgE)IBA 02/2019 - 07/2005
4	Phenobarbital (Luminal)FDA Link 01/2019 - 06/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 03/2009
4	Tiotropium Bromide (Spiriva)FDA Link 02/2015 - 12/2008
4	AcidsIBA 04/2012 - 01/2005
3	Bronchodilator Agents (Bronchodilators)IBA 05/2022 - 01/2015
3	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 03/2022 - 07/2016
3	Olanzapine (Zyprexa)FDA Link 03/2022 - 01/2019

Therapy/Procedure

71	Therapeutics 07/2022 - 06/2002
25	Drug Therapy (Chemotherapy) 03/2022 - 04/2008
4	Artificial Respiration (Mechanical Ventilation) 04/2022 - 02/2005
3	Aftercare (After-Treatment) 01/2022 - 09/2005